Form 4: Iovance Biotherapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Frederick G Vogt, Interim CEO & General Counsel and a Director of Iovance Biotherapeutics, Inc., reported multiple transactions in common stock on September 8, 2026.
Summary
- Option exercise/conversion: acquired 15,626 Common Stock on September 8, 2026; holds 602,085 after (Direct).
- Tax/exercise-price withholding: disposed of 6,638 Common Stock at $8.70 ($57,751) on September 8, 2026; holds 595,447 after (Direct).
- Option exercise/conversion: disposed of 15,626 Restricted Stock Units on September 8, 2026; holds 93,756 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Frederick G Vogt — Director, Officer (Interim CEO & General Counsel)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 15,626 | — | — | 602,085 |
| 2026-09-08 | Tax/exercise-price withholding | Common Stock | 6,638 | $9 | $57.8K | 595,447 |
| 2026-09-08 | Option exercise/conversion | Restricted Stock Units | 15,626 | — | — | 93,756 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (15,626 shares) |
| 2026-09-08 | Tax/exercise-price withholding (6,638 shares) |
| 2026-09-08 | Option exercise/conversion (15,626 shares) |
Keywords
insider transaction, Form 4, IOVA, IOVANCE BIOTHERAPEUTICS, INC., neutral, Frederick G Vogt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.